AbbVie 2014 Annual Report Download - page 121

Download and view the complete annual report

Please find page 121 of the 2014 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 182

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182

13NOV201221352027
14FEB201503004602
13FEB201501375473
13NOV201221352027
PROXY STATEMENT SUMMARY
The accompanying proxy is solicited on behalf of the board of directors for use at the Annual Meeting of
Stockholders. The meeting will be held on May 8, 2015, at the Fairmont Chicago, Millennium Park, 200 North Columbus
Drive, Chicago, Illinois 60601. This summary highlights selected information in the Proxy Statement. Please review the
entire Proxy Statement and the AbbVie 2014 Annual Report before voting.
2015 Annual Meeting of Stockholders
................................................................................................................................................................................................................................................................................................................................................................................................
Date and Time: May 8, 2015 9:00 a.m. CT
Location: Fairmont Chicago, Millennium Park, 200 North Columbus Drive, Chicago, Illinois 60601
Record Date: March 11, 2015
How to Vote: Stockholders as of the record date are entitled to vote via Internet at www.proxyvote.com; by telephone at
1-800-690-6903; by returning a completed proxy card; or in person at the Annual Meeting of Stockholders.
Voting Items and Board Recommendations
................................................................................................................................................................................................................................................................................................................................................................................................
Board Recommendations
Item 1 Election of Directors FOR All Nominees
Item 2 Ratification of Independent Auditor FOR
Item 3 Say on Pay—Advisory Vote on the Approval of Executive Compensation FOR
Business Overview and Performance Highlights
................................................................................................................................................................................................................................................................................................................................................................................................
Business Overview. AbbVie is a global, research-based biopharmaceutical company that develops and markets
advanced therapies for some of the world’s most complex and serious diseases. Our products support the treatment of
conditions such as chronic autoimmune disease (including rheumatoid arthritis, psoriasis, and Crohn’s disease), hepatitis C
virus (HCV), human immunodeficiency virus (HIV), endometriosis, thyroid disease, Parkinson’s disease, complications
associated with cystic fibrosis, and other health conditions. Our pipeline includes more than 40 compounds or indications
in development across important medical specialties such as immunology, virology/liver disease, oncology, renal disease,
neurological diseases, and women’s health.
2015 Proxy Statement 1